Preoperative treatment of a presensitized kidney transplant recipient with donor-derived transplant acceptance-inducing cells

Transplant International

Volumn 21, Issue 8, 2008, Pages 808-813

  Hutchinson, James A ^a   Roelen, Dave ^b   Riquelme, Paloma ^a   Brem Exner, Beate G ^a   Witzke, Oliver ^c   Philipp, Thomas ^c   Matthäi, Martina ^a   Gövert, Felix ^a   Claas, Frans H J ^b   Westphal, Eckhard ^a   Kunzendorf, Ulrich ^a   Geissler, Edward K ^d   Fändrich, Fred ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cell based immunotherapy; TAIC; Tolerance; Transplantation

Indexed keywords

ALLOANTIGEN; ATG FRESENIUSS; HLA ANTIBODY; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; PREDNISOLONE SODIUM SUCCINATE; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; ALLOANTIBODY; HLA ANTIGEN;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CASE REPORT; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; PREOPERATIVE CARE; PRIORITY JOURNAL; RECIPIENT; TRANSPLANT ACCEPTANCE INDUCING CELL; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME; TREATMENT RESPONSE; BIOLOGICAL THERAPY; DONOR; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MACROPHAGE; MIXED LYMPHOCYTE CULTURE;

ADULT; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, INTRAVENOUS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; LYMPHOCYTE CULTURE TEST, MIXED; MACROPHAGES; MALE; TISSUE DONORS; TISSUE THERAPY; TRANSPLANTATION CONDITIONING; TRANSPLANTATION TOLERANCE;

EID: 58149204330     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2008.00712.x     Document Type: Article

References (15)

1. Cecka JM, Zhang Q, Reed EF. Preformed cytotoxic antibodies in potential allograft recipients: recent data. Hum Immunol 2005; 66: 343.
2. Hutchinson JA, Riquelme P, Brem-Exner BG, et al. Transplant acceptance-inducing cells as an immune-conditioning therapy in renal transplantation. Transpl Int: 10.1111/j.1432-2277.2008.00680.x [E-pub ahead of print].
3. Hutchinson JA, Brem-Exner BG, Riquelme P, et al. A cell-based approach to the minimization of immuno-suppression in renal transplantation. Transpl Int: 10.1111/j.1432-2277.2008.00692.x [E-pub ahead of print].
4. Heumann A, Ungefroren H, Ruhnke M, et al. Charakteri-sierung nichtdendritischer monozytärer Zellen mit Immunregulatorischen Eigenschaften. Deutsche Gesellschaft für Chirurgie Chirurgisches Forum 2005 [abstract]. 2005; 34: 271.
5. Exner BG, Scherer MN, Koehl GE, et al. Hyperacute rejection of transplanted rat hearts is abrogated by the use of in vitro generated donor-derived transplant-acceptance-inducing cells (TAIC). Transplantation 2004; 78(Suppl. 1): 530.
6. Brem-Exner BG, Sattler C, Hutchinson JA, et al. Macro-phages driven to a novel state of activation have anti-inflammatory properties in mice. J Immunol 2008; 180: 335.
7. Kabelitz D, Geissler EK, Soria B, Schroeder IS, Fändrich F, Chatenoud L. Toward cell-based therapy of type I diabetes. Trends Immunol 2008; 29: 68.
8. Brent L, Brooks CG, Medawar PB, Simpson E. Transplantation tolerance. Br Med Bull 1976; 32: 101.
9. Burlingham WJ. The blood transfusion effect. In: Thiru S, Waldmann H, eds. Pathology and Immunology of Transplantation and Rejection. Oxford: Blackwell Sciences, 2001: 92-115.
10. Salvatierra O, Vincenti F, Amend W, et al. Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg 1980; 192: 543.
11. Flye MW, Burton K, Mohanakumar T, et al. Donor-specific transfusions have long-term beneficial effects for human renal allografts. Transplantation 1995; 60: 1395.
12. Opelz G, Sengar GPS, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 4: 253.
13. Anderson CB, Sicard GA, Etheredge EE. Pretreatment of renal allograft recipients with azathioprine and donor-specific blood products. Surgery 1982; 92: 315.
14. Glass NR, Miller DT, Sollinger HW, Belzer FO. A four-year experience with donor blood transfusion protocols for living-donor renal transplantation. Transplantation 1985; 39: 615.
15. Hardy MA, Suciu-Foca N, Reed E, et al. Immunomodula-tion of kidney and heart transplants by anti-idiotypic antibodies. Ann Surg 1991; 214: 522.